BK viremia can lead to nephritis, which can progress to irreversible kidney transplant failure. This prospective study provides management and outcome of BK viremia in renal transplant recipients.
The study concludes that reduction in immunosuppression alone resulted in the successful resolution of viremia with preservation of renal function and prevention of clinical BKV nephritis and graft loss.
“Management and Outcome of BK Viremia in Renal Transplant Recipients: A Prospective Single-Center Study” was published in the October 27 issue of Transplantation. Sundaram Hariharan, MD, medical director, UPMC Kidney and Pancreas Transplantation Program provides some additional information about it in his video blog.